The Center for Heart Failure Research (CHFR) was established in 2002 and has since then promoted the integration of high quality research from bench to bedside. Center members have a broad range of expertise, covering state-of-the-art gene technology, protein function, integrative physiology in pathophysiological models and clinical studies. This collective knowledge and active research collaboration has resulted in more than 200 scientific publications each year.
Several members of the Cardiac genetic diseases and sudden cardiac death research group presented interesting results from their recent studies. Two PhD fellows were awarded with the best poster prize; Eystein Skjølsvik for his work on “Exercise is a marker of impaired left ventricular function in patients with Lamin A/C mutations” and Monica Chivulescu for her work on “High penetrance and similar disease progression in probands and family members with arrhythmogenic cardiomyopathy”.
The later study was first published at the ESC Congress a month ago, in additon to being featured in Dagens Medisin, a Norwegian news outlet focusing on healthcare. In the interwiev with Dagens Medisin professor Kristina Haugaa tells that the results from this study suggest that family members of patients with ARVC should receive closer follow-up than they do now. Consultant Cardiologist Pål Tande from UNN (University Hospital of North Norway) agrees with prof. Haugaa that the study is a good argument for systematic screening of family members of patients with ARVC.
Previous best poster prize winner in the session Diagnostic and therapeutical strategies for cardiac disease postdoctoral fellow Øyvind H. Lie, was among the speakeres at this year's Symposium. Lie talked about Cardiac arrest in sports: Knowledge and misconceptions. Øyvind H. Lie has also written about the subject in, among others, Indremedisineren and Aftenposten.